Target Price | $8.16 |
Price | $5.20 |
Potential |
56.92%
register free of charge
|
Number of Estimates | 7 |
7 Analysts have issued a price target AVITA Therapeutics 2026 .
The average AVITA Therapeutics target price is $8.16.
This is
56.92%
register free of charge
$14.70
182.69%
register free of charge
$3.03
41.73%
register free of charge
|
|
A rating was issued by 13 analysts: 10 Analysts recommend AVITA Therapeutics to buy, 1 to hold and 2 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the AVITA Therapeutics stock has an average upside potential 2026 of
56.92%
register free of charge
|
Dec '24 |
2025 Estimates |
|
---|---|---|
Revenue Million $ | 64.25 | 78.98 |
28.14% | 22.92% | |
EBITDA Margin | -85.40% | -40.08% |
2.64% | 53.07% | |
Net Margin | -96.26% | -35.95% |
36.42% | 62.66% |
9 Analysts have issued a sales forecast AVITA Therapeutics 2025 . The average AVITA Therapeutics sales estimate is
This results in the following potential growth metrics:
6 Analysts have issued an AVITA Therapeutics EBITDA forecast 2025. The average AVITA Therapeutics EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
9 AVITA Therapeutics Analysts have issued a net profit forecast 2025. The average AVITA Therapeutics net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share $ | -2.39 | -1.07 |
70.71% | 55.23% | |
P/E | negative | |
EV/Sales | 2.09 |
9 Analysts have issued a AVITA Therapeutics forecast for earnings per share. The average AVITA Therapeutics EPS is
This results in the following potential growth metrics and future valuations:
AVITA Therapeutics...
Analyst | Rating | Action | Date |
---|---|---|---|
D. Boral Capital |
Locked
➜
Locked
|
Locked | Sep 15 2025 |
D. Boral Capital |
Locked
➜
Locked
|
Locked | Sep 05 2025 |
Lake Street |
Locked
➜
Locked
|
Locked | Aug 11 2025 |
D. Boral Capital |
Locked
➜
Locked
|
Locked | Aug 08 2025 |
D. Boral Capital |
Locked
➜
Locked
|
Locked | Jun 10 2025 |
D. Boral Capital |
Locked
➜
Locked
|
Locked | Jun 06 2025 |
D. Boral Capital |
Locked
➜
Locked
|
Locked | Apr 10 2025 |
Analyst Rating | Date |
---|---|
Locked
D. Boral Capital:
Locked
➜
Locked
|
Sep 15 2025 |
Locked
D. Boral Capital:
Locked
➜
Locked
|
Sep 05 2025 |
Locked
Lake Street:
Locked
➜
Locked
|
Aug 11 2025 |
Locked
D. Boral Capital:
Locked
➜
Locked
|
Aug 08 2025 |
Locked
D. Boral Capital:
Locked
➜
Locked
|
Jun 10 2025 |
Locked
D. Boral Capital:
Locked
➜
Locked
|
Jun 06 2025 |
Locked
D. Boral Capital:
Locked
➜
Locked
|
Apr 10 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.